Femasys Inc. (NASDAQ:FEMY) Sees Large Increase in Short Interest

Femasys Inc. (NASDAQ:FEMY) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 298,300 shares, an increase of 106.2% from the January 31st total of 144,700 shares. Based on an average trading volume of 275,300 shares, the short-interest ratio is presently 1.1 days. Currently, 1.4% of the company’s stock are short sold.

Femasys Stock Down 1.3 %

Shares of FEMY traded down $0.02 during midday trading on Friday, hitting $1.57. 145,280 shares of the company’s stock traded hands, compared to its average volume of 275,784. The company has a current ratio of 3.94, a quick ratio of 3.26 and a debt-to-equity ratio of 0.86. The stock has a market capitalization of $35.95 million, a price-to-earnings ratio of -1.94 and a beta of -2.81. Femasys has a 1 year low of $0.86 and a 1 year high of $2.40. The firm’s fifty day moving average is $1.24 and its 200-day moving average is $1.17.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Chardan Capital dropped their price objective on Femasys from $10.00 to $8.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. HC Wainwright restated a “buy” rating and issued a $12.00 price target on shares of Femasys in a report on Wednesday.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC boosted its holdings in Femasys by 4.7% in the fourth quarter. Geode Capital Management LLC now owns 216,164 shares of the company’s stock worth $238,000 after acquiring an additional 9,681 shares in the last quarter. XTX Topco Ltd raised its position in shares of Femasys by 123.9% in the 3rd quarter. XTX Topco Ltd now owns 32,535 shares of the company’s stock valued at $36,000 after purchasing an additional 18,004 shares during the last quarter. Virtu Financial LLC acquired a new stake in Femasys in the 4th quarter worth approximately $25,000. Aljian Capital Management LLC purchased a new stake in Femasys during the 3rd quarter worth approximately $27,000. Finally, Jane Street Group LLC purchased a new stake in Femasys during the 4th quarter worth approximately $30,000. 65.27% of the stock is owned by institutional investors and hedge funds.

About Femasys

Femasys Inc, a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.